Alzheimer's treatment: Eli Lilly's drug promises to slow worsening by 22% Eli Lilly and Co. has said it applied for full US approval of its Alzheimer’s disease drug. If approved this will be the second effective drug to combat the mind-robbing disease, after Japanese drugmaker Eisai developed Leqembi.
Alzheimer's treatment: Eli Lilly's drug promises to slow worsening by 22%
- Konuyu başlatan Hasan
- Başlangıç tarihi